Kapp J A, Pierce C W, De la Croix F, Benacerraf B
J Immunol. 1976 Feb;116(2):305-9.
The synthetic terpolymer of L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) not only fails to elicit a GAT-specific antibody response in nonresponder mice, but also prior injection of GAT specifically decreases the ability of nonresponder mice to develop a GAT-specific antibody response to a subsequent challenge with GAT-MBSA. This inhibition is mediated by GAT-specific suppressor T cells. Further, a suppressive factor can be extracted from lymphoid cells of GAT-primed nonresponder mice that inhibits the development of primary GAT-specific antibody responses to GAT-MBSA and to GAT-PRBC- by normal syngeneic mice. The suppressive activity is dose-dependent and absorbed by GAT-Sepharose, but not by BSA-Sepharose. The suppressive activity elutes from a G-100 Sephadex column in the same fraction as ovalbumin, suggesting its m.w. is approximately 45,000 daltons.
L-谷氨酸60-L-丙氨酸30-L-酪氨酸10(GAT)的合成三元共聚物不仅无法在无反应小鼠中引发GAT特异性抗体反应,而且预先注射GAT会特异性降低无反应小鼠对随后用GAT-MBSA进行攻击产生GAT特异性抗体反应的能力。这种抑制作用由GAT特异性抑制性T细胞介导。此外,可从经GAT致敏的无反应小鼠的淋巴细胞中提取一种抑制因子,该因子可抑制同基因正常小鼠对GAT-MBSA和GAT-PRBC产生原发性GAT特异性抗体反应。抑制活性呈剂量依赖性,可被GAT-琼脂糖吸附,但不能被BSA-琼脂糖吸附。抑制活性从G-100葡聚糖凝胶柱上洗脱的组分与卵清蛋白相同,表明其分子量约为45,000道尔顿。